Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity

P Meier, AJ Legrand, D Adam, J Silke - Nature Reviews Cancer, 2024 - nature.com
Most metastatic cancers remain incurable due to the emergence of apoptosis-resistant
clones, fuelled by intratumour heterogeneity and tumour evolution. To improve treatment …

Comparing the effects of different cell death programs in tumor progression and immunotherapy

MN Messmer, AG Snyder, A Oberst - Cell Death & Differentiation, 2019 - nature.com
Our conception of programmed cell death has expanded beyond apoptosis to encompass
additional forms of cell suicide, including necroptosis and pyroptosis; these cell death …

Necroptotic cell death in anti‐cancer therapy

O Krysko, TL Aaes, VE Kagan, K D'Herde… - Immunological …, 2017 - Wiley Online Library
Necroptosis is one the best‐characterized forms of regulated necrosis. Necroptosis is
mediated by the kinase activities of receptor interacting protein kinase‐1 and receptor …

[HTML][HTML] Necroptosis in immuno-oncology and cancer immunotherapy

J Sprooten, P De Wijngaert, I Vanmeerbeek, S Martin… - Cells, 2020 - mdpi.com
Immune-checkpoint blockers (ICBs) have revolutionized oncology and firmly established the
subfield of immuno-oncology. Despite this renaissance, a subset of cancer patients remain …

Relevance of necroptosis in cancer

N Lalaoui, G Brumatti - Immunology and cell biology, 2017 - Wiley Online Library
Resistance to caspase‐dependent apoptosis is often responsible for treatment failures in
cancer. Finding novel therapeutic strategies that can activate alternative cell death programs …

Cell death, therapeutics, and the immune response in cancer

K Hänggi, B Ruffell - Trends in cancer, 2023 - cell.com
Induction of cell death is inexorably linked with cancer therapy, but this can also initiate
wound-healing processes that have been linked to cancer progression and therapeutic …

[HTML][HTML] Necroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapy

MB Meng, HH Wang, YL Cui, ZQ Wu, YY Shi… - Oncotarget, 2016 - ncbi.nlm.nih.gov
While the mechanisms underlying apoptosis and autophagy have been well characterized
over recent decades, another regulated cell death event, necroptosis, remains poorly …

[HTML][HTML] Immunogenic cell death in cancer immunotherapy

M Choi, J Shin, CE Lee, JY Chung, M Kim, X Yan… - BMB …, 2023 - ncbi.nlm.nih.gov
Cancer immunotherapy has been acknowledged as a new paradigm for cancer treatment,
with notable therapeutic effects on certain cancer types. Despite their significant potential …

Necroptosis and tumor progression

J Yan, P Wan, S Choksi, ZG Liu - Trends in cancer, 2022 - cell.com
Necroptosis, a form of programmed necrotic cell death, is a gatekeeper of host defense
against certain pathogen invasions. The deregulation of necroptosis is also a key factor of …

Therapeutic exploitation of necroptosis for cancer therapy

S Fulda - Seminars in cell & developmental biology, 2014 - Elsevier
Evasion of programmed cell death represents one of the hallmarks of cancers that
contributes to tumor initiation, progression and treatment resistance. This calls for novel …